NORD and Partners Host FDA, CDC Leaders in Webinar Addressing Rare Disease Community on COVID-19 Vaccines

Print Friendly, PDF & Email

WASHINGTONJan. 26, 2021 /PRNewswire/ — In an effort to provide clear, useful, authoritative information to rare disease patients and caregivers on the COVID-19 vaccines, on January 15 the National Organization for Rare Disorders (NORD®), along with The ALS Association, Cystic Fibrosis Foundation and Muscular Dystrophy Association, hosted a special webinar with leaders from the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). In December 2020 FDA granted Emergency Use Authorization (EUA) for the Pfizer-BioNTech and Moderna vaccines against COVID-19, which are now being distributed.

Click here for the full article and link to the on-demand recording.